Introduction:In contrast with Escherichia coli, the association of E. hermanii with urinary tract infections has not been described.Case Presentation:In this case, E. hermanii was the sole isolate recovered from urine specimens of a pyelonephritis patient. The organism was found to be susceptible to piperacillin-tazobactam, ceftazidime, cefazolin, cefixime, aztreonam, gentamicin, tobramycin, imipenem, meropenem and amikacin, and resistant to amoxicillin. Antibiotic treatment was initiated with oral cefixime (400 mg every 24 hours). The symptoms were relieved within 72 hours after therapy. A urine sample was taken seven days after antibiotic therapy. E. hermanii was no longer isolated.Discussion:The present case demonstrates that the uropathogenic E. hermanii clone can cause destruction of the kidneys. During asymptomatic bacteriuria or cystitis, the bacteria remain in the urinary tract. Even when pyelonephritis develops, inflammatory response of the host is still restricted to the urinary tract. These signs mean that uropathogenic E. hermanii may be not very virulent.
Background:Plasmid transfer among bacteria provides a means for dissemination of resistance. Plasmid Analysis has made it possible to track plasmids that induce resistance in bacterial population.Objectives:To screen the presence of herb-resistance plasmid in Escherichia coli strains and determine the transferability of this resistance plasmid directly from E. coli to the Gram-positive, Staphylococcus aureus.Materials and Methods:The donor strain E. coli CP9 and recipient strain S. aureus RN450RF were isolated from UTI patients. E. coli CP9 was highly resistant to herbal concoction. Isolates of S. aureus RN450RF were fully susceptible. Total plasmid DNA was prepared and transferred into E. coli DH5α. Transconjugants were selected on agar plates containing serial dilutions of herbal concoction. Resistance plasmid was transferred to susceptible S. aureus RN450RFin triple replicas. The mating experiments were repeated twice.Results:The identified 45 kb herb-resistance plasmid could be transferred from E. coli CP9 isolates to E. coli DH5α. As a consequence E. coli DH5α transconjugant MIC increased from 0.0125 g/mL to 0.25 g/mL. The plasmid was easily transferred from E. coli CP9 strain to S. aureus RN450RF with a mean transfer rate of 1×10-2 transconjugants/recipient. The E. coli donor and the S. aureus RN450RF transconjugant contained a plasmid of the same size, which was absent in the recipient before mating. Susceptibility testing showed that the S. aureus RN450RF transconjugant was resistant to herbal concoction.Conclusions:E. coli herb-resistance plasmid can replicate and be expressed in S. aureus.
A 48-year-old asian man was admitted to hospital for the consideration of hemodialysis (HD). An adequate site was decided on for the AVF after Doppler ultrasonography examination of radial artery and cephalic vein. The AVF was formed under local anaesthetic at his right wrist. When seen at the clinic appointment one month later, the AVF was not working. The subsequent Doppler ultrasonography examination revealed two straight shunts at draining vein. The failure of AVF is due to impaired outflow following reduction of the resistance between draining vein and peripheral venous system. Key words: Arteriovenous fistula; Shunts; Hemodialysis; Ultrasonography; Draining vein.The National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines for Vascular Access recommend increasing the proportion of arteriovenous fistula (AVF) among hemodialysis (HD) patients (Clinical practice guidelines for vascular access, 2006). Adherence to these recommendations has increased the prevalence of AVF at wrist in Chinese HD patients. A major hurdle to increasing further the proportion of AVF use is the high rate of primary AVF failures (AVF never usable for HD) (Allon et al., 2002). A case of AVF failure due to two straight shunts formation at draining vein is reported.
Case reportThe patient was a 48-year-old asian man with a history of chronic renal failure. His medication included ferrous sulphate 300mg, three times daily; folacin 10mg, three times daily; rhEPO 3000u, two times weekly; nifedipine, 10mg, three times daily; and salt restriction. He was admitted to the hospital for consideration of HD with the IgA nephropathy as the primary disease. Doppler ultrasonography examination of radial artery and cephalic vein was performed before the operation. The cephalic vein was assessed as suitable ( Figure 1) with no shunts found. An adequate site was decided on for AVF.The AVF was formed under local anaesthetic at his right wrist. The radial artery and cephalic vein were exposed through longitudinal incision. The vein was freed by wide dissection and the collateral branch was ligated with microsurgical clips. A transverse section was made with ligature of the distal branch, followed by a longitudinal veinotomy of the posterior wall of the cephalic vein. The anterior wall of the artery was exposed without any dissection of its trunk. A longitudinal arteriotomy of 15mm in length was made. Then artery-to-vein, side-to-end anastomosis was performed. Attention was paid to avoid twisting the vein. When anastomosis was completed, the tourniquet was released. Additional sutures were added in the case of leak. Hand exercises, such as squeezing a rubber ball at frequent intervals, were recommended in the postoperative period.After the operation, the fistula functioned briefly. But when seen at the clinic appointment one month later, the AVF was not working. The thrill of AVF to auscultation and palpation disapeared. The subsequent ultrasonography examination revealed two straight shunts at draining vein (Figure ...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.